- Home
- PDX vs RXST Comparison
PDX vs RXST Comparison
Compare PDX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDX
- RXST
- Stock Information
- Founded
- PDX 2019
- RXST 1997
- Country
- PDX NY
- RXST United States
- Employees
- PDX N/A
- RXST N/A
- Industry
- PDX Finance/Investors Services
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PDX Finance
- RXST Health Care
- Exchange
- PDX Nasdaq
- RXST Nasdaq
- Market Cap
- PDX 1.1B
- RXST 1.0B
- IPO Year
- PDX N/A
- RXST 2021
- Fundamental
- Price
- PDX $21.13
- RXST $14.43
- Analyst Decision
- PDX
- RXST Buy
- Analyst Count
- PDX 0
- RXST 10
- Target Price
- PDX N/A
- RXST $38.50
- AVG Volume (30 Days)
- PDX N/A
- RXST 1.2M
- Earning Date
- PDX 01-01-0001
- RXST 05-07-2025
- Dividend Yield
- PDX 4.95%
- RXST N/A
- EPS Growth
- PDX N/A
- RXST N/A
- EPS
- PDX N/A
- RXST N/A
- Revenue
- PDX N/A
- RXST $139,927,000.00
- Revenue This Year
- PDX N/A
- RXST $24.34
- Revenue Next Year
- PDX N/A
- RXST $21.83
- P/E Ratio
- PDX N/A
- RXST N/A
- Revenue Growth
- PDX N/A
- RXST 57.09
- 52 Week Low
- PDX $13.52
- RXST $13.50
- 52 Week High
- PDX $21.05
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- PDX 41.37
- RXST 25.56
- Support Level
- PDX $20.32
- RXST $13.79
- Resistance Level
- PDX $20.88
- RXST $14.93
- Average True Range (ATR)
- PDX 1.23
- RXST 1.34
- MACD
- PDX -0.12
- RXST -0.29
- Stochastic Oscillator
- PDX 31.53
- RXST 9.78
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.